BioPharma Dive
Tracey Beth Høeg, top Makary deputy, named head of FDA drug office
Høeg, a COVID-19 vaccine critic who’s been serving as a special assistant to the commissioner, will be the fifth person this ...
MPR
Fourth FDA Drug Chief This Year Steps Down, Raising Stability Concerns
Pazdur reportedly questioned whether a new FDA program called the Commissioner’s National Priority Voucher, designed to speed reviews for drugs tied to national priorities, was transparent or even ...
FDA drug chief Pazdur felt undercut by Marty Makary in lead-up to resignation: Peter Pitts | CUOMO
Peter Pitts, a former associate commissioner of the FDA, joins "CUOMO" to discuss the resignation of Dr. Richard Pazdur, the ...
Industry, investor worries hang over Makary
Under pressure: Meanwhile, leaders in the biotech and investment spaces are beginning to more publicly critique Makary’s ...
News4Jax
FDA names longtime cancer scientist Pazdur to lead drug center
FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File) (Jose Luis Magana) Dr. Richard Pazdur, ...
NBC 10 Philadelphia
Healthy Returns: Trump's FDA pick Makary may be a relief for biotech and pharma, analysts say
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Tuesday ...
Hosted on MSN
FDA moves to lift ‘black box’ warnings from hormone therapies for menopause symptoms
The U.S. Food and Drug Administration (FDA) announced it is initiating the removal of "black box" warning labels from hormone replacement therapy (HRT) products used to ease menopause symptoms, a move ...